0001341004-13-000585.txt : 20130524 0001341004-13-000585.hdr.sgml : 20130524 20130524170341 ACCESSION NUMBER: 0001341004-13-000585 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130524 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20130524 DATE AS OF CHANGE: 20130524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 13872802 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 8-K 1 form8-k.htm form8-k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  May 24, 2013

MYLAN INC.
(Exact Name of Registrant as Specified in Charter)

 
Pennsylvania
  
1-9114
  
25-1211621
(State or Other Jurisdiction of Incorporation)
  
(Commission File Number)
  
(I.R.S. Employer Identification No.)
         

1500 Corporate Drive, Canonsburg, PA
  
 
15317
(Address of Principal Executive Offices)
  
(Zip Code)

Registrant’s telephone number, including area code: (724) 514-1800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

 
 
 

Item 5.07.             Submission of Matters to a Vote of Security Holders.
 
The 2013 Annual Meeting of Shareholders of Mylan Inc. (the “Company”) was held on May 24, 2013 to (i) elect thirteen members of the Board of Directors for one year terms; (ii) ratify the appointment of Deloitte & Touche LLP as its independent registered public accounting firm; (iii) approve, on an advisory basis, the compensation of the Named Executive Officers of the Company, as disclosed in the Proxy Statement; and (iv) consider a shareholder proposal requesting the adoption of a mandatory policy requiring that the Chairman of the Board of Directors be an independent Director.
 
As of March 22, 2013, the record date for the Annual Meeting, there were 382,710,089 shares of common stock outstanding and entitled to vote. At the Annual Meeting, approximately 303,517,781 shares of common stock were represented in person or by proxy, constituting a quorum. The certified results of the matters voted on at the Annual Meeting are set forth below.
 
Proposal No. 1 – Elect the following thirteen directors, each for a term of one year:
 
 
For
  
Against
  
Abstain
  
Broker Non-Votes
Heather Bresch
260,211,010
  
3,970,967
  
6,953,513
  
32,382,291
Wendy Cameron
244,270,900
  
17,142,083
  
9,722,504
  
32,382,293
Robert J. Cindrich
259,641,969
  
1,760,491
  
9,733,030
  
32,382,290
Robert J. Coury
258,778,975
  
5,309,787
  
7,046,726
  
32,382,292
Neil Dimick, C.P.A.
229,609,477
  
31,844,796
  
9,681,217
  
32,382,290
Melina Higgins
261,430,378
  
2,599,221
  
7,105,892
  
32,382,289
Douglas J. Leech, C.P.A.
258,133,428
  
3,318,807
  
9,683,253
  
32,382,291
Rajiv Malik
260,368,054
  
3,787,198
  
6,980,239
  
32,382,289
Joseph C. Maroon, M.D.
245,005,887
  
15,742,485
  
10,430,548
  
32,338,861
Mark W. Parrish
259,882,269
  
1,559,479
  
9,698,744
  
32,382,288
Rodney L. Piatt, C.P.A.
246,068,258
  
15,400,800
  
9,665,833
  
32,382,289
C.B. Todd
257,365,913
  
3,929,609
  
9,839,967
  
32,382,291
Randall L. (Pete) Vanderveen, Ph.D., R.Ph., C.P.A
258,320,492
  
3,225,371
  
9,589,626
  
32,382,290

 
Proposal No. 2 – Ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2013:
 
For
  
Against
  
Abstain
  
Broker Non-Votes
291,898,777
  
4,268,282
  
7,307,291
  
43,429

 
Proposal No. 3 – Approve, on an advisory basis, the compensation of the Named Executive Officers of the Company, as disclosed in the Proxy Statement:
 
For
  
Against
  
Abstain
  
Broker Non-Votes
185,440,201
  
80,499,909
  
5,195,372
  
32,382,297

 
Proposal No. 4 – Consider a shareholder proposal requesting the adoption of a mandatory policy requiring that the Chairman of the Board of Directors be an independent Director:
 
For
  
Against
  
Abstain
  
Broker Non-Votes
111,935,681
  
157,406,691
  
1,793,109
  
32,382,299
 
 
 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
MYLAN INC.
Date: May 24, 2013
By:  
/s/ John D. Sheehan
   
John D. Sheehan
   
Executive Vice President and Chief Financial Officer